Connor, Clark & Lunn Investment Management (CC&L)’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,947
Closed -$488K 1390
2023
Q3
$488K Sell
5,947
-5,881
-50% -$517K ﹤0.01% 1023
2023
Q2
$1.11M Sell
11,828
-5,786
-33% -$462K 0.01% 768
2023
Q1
$1.2M Sell
17,614
-1,760
-9% -$142K 0.01% 672
2022
Q4
$1.38M Buy
19,374
+2,232
+13% +$152K 0.01% 626
2022
Q3
$1.06M Sell
17,142
-3,968
-19% -$286K 0.01% 640
2022
Q2
$1.41M Sell
21,110
-9,823
-32% -$738K 0.01% 542
2022
Q1
$2.22M Buy
30,933
+2,103
+7% +$172K 0.01% 482
2021
Q4
$2.76M Buy
+28,830
New +$1.95M 0.01% 458
2019
Q1
Sell
-35,212
Closed -$870K 913
2018
Q4
$870K Sell
35,212
-10,163
-22% -$249K 0.01% 578
2018
Q3
$1.43M Buy
45,375
+18,850
+71% +$679K 0.01% 501
2018
Q2
$995K Sell
26,525
-3,225
-11% -$126K 0.01% 614
2018
Q1
$970K Buy
+29,750
New +$553K 0.01% 486

Other funds holding BXC

Connor, Clark & Lunn Investment Management (CC&L)'s BXC Position: Q4 2023 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BlueLinx (BXC) in Q4 2023, closing a stake of 5,947 shares — an estimated $488K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BXC in Q1 2018 and held it in 12 quarters. The position peaked at $2.76M in Q4 2021. 168 funds tracked by Wall St. Rank hold BXC as of Q4 2023.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BlueLinx position as of Q4 2023 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 5,947 BlueLinx shares in Q4 2023, an estimated $488K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BlueLinx in Q1 2018 and held it in 12 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s BlueLinx position peaked at $2.76M in Q4 2021.
  • 168 funds tracked by Wall St. Rank held BlueLinx as of Q4 2023.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2023, filed 9 Feb 2024.